Laetitia Cousin Biography and Net Worth

SVP of Insulet

Ms. Cousin has served as our Senior Vice President, Regulatory Affairs, Quality Assurance and Compliance since December 2022. She brings to Insulet over 25 years of regulatory, quality, and clinical experience in the medical device industry. Prior to joining Insulet, Ms. Cousin led the Regulatory, Quality Compliance, Quality Operations and Environmental Health and Safety functions at SeaSpine Holdings Corporation, a global medical technology company. Previously, Ms. Cousin worked as Vice President, Regulatory, Clinical Affairs, and Quality Assurance at NuVasive, Inc. for 16 years in similar roles with increasing levels of responsibility. She began her career at Tyco Healthcare as an R&D Associate. Ms. Cousin earned a Bachelor of Science in Biological Sciences from Florida Institute of Technology in Melbourne, Florida.

What is Laetitia Cousin's net worth?: The estimated net worth of Laetitia Cousin is at least $1.23 million as of September 8th, 2025. Cousin owns 3,890 shares of Insulet stock worth more than $1,228,929 as of December 5th. This net worth evaluation does not reflect any other investments that Cousin may own. Learn More about Laetitia Cousin's net worth.
How old is Laetitia Cousin?: Cousin is currently 48 years old. There are 9 older executives and no younger executives at Insulet. The oldest executive at Insulet is Mr. John Wodick Kapples, Senior VP & General Counsel, who is 64 years old. Learn More on Laetitia Cousin's age.
How do I contact Laetitia Cousin?: The corporate mailing address for Cousin and other Insulet executives is 100 NAGOG PARK, ACTON MA, 01720. Insulet can also be reached via phone at (978) 600-7000 and via email at [email protected]. Learn More on Laetitia Cousin's contact information.
Has Laetitia Cousin been buying or selling shares of Insulet?: Laetitia Cousin has not been actively trading shares of Insulet during the last ninety days. Most recently, Laetitia Cousin sold 797 shares of the business's stock in a transaction on Monday, September 8th. The shares were sold at an average price of $348.81, for a transaction totalling $278,001.57. Following the completion of the sale, the senior vice president now directly owns 3,890 shares of the company's stock, valued at $1,356,870.90. Learn More on Laetitia Cousin's trading history.
Who are Insulet's active insiders?: Insulet's insider roster includes Charles Alpuche (COO), Eric Benjamin (SVP), Luciana Borio (Director), Lauren Budden (Group Vice President, CAO and Controller), Bret Christensen (EVP), Laetitia Cousin (SVP), Sally Crawford (Director), John Fallon (Director), Mark Field (SVP and Chief Technology Officer), Wayne Frederick (Director), James Hollingshead (CEO), John Kapples (Senior Vice President and General Counsel), Dan Manea (SVP), Wayde McMillan (CFO), Shacey Petrovic (CEO), Timothy Scannell (Director), Prem Singh (SVP), and Michael Spears (SVP). Learn More on Insulet's active insiders.
Are insiders buying or selling shares of Insulet?: In the last twelve months, insiders at the medical instruments supplier sold shares 6 times. They sold a total of 21,896 shares worth more than $6,421,999.16. The most recent insider tranaction occured on September, 8th when SVP Prem Singh sold 687 shares worth more than $238,725.63. Insiders at Insulet own 0.4% of the company. Learn More about insider trades at Insulet.
Information on this page was last updated on 9/8/2025.

Laetitia Cousin Insider Trading History at Insulet

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/8/2025	Sell	797	$348.81	$278,001.57	3,890

Laetitia Cousin Buying and Selling Activity at Insulet

Insulet Company Overview

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Today's Range

Now: $315.92

$305.05

$317.34

50 Day Range

MA: $320.58

$305.98

$346.36

2 Week Range

Now: $315.92

$230.05

$354.88

Volume

757,024 shs

Average Volume

779,667 shs

Market Capitalization

$22.22 billion

P/E Ratio

91.57

Dividend Yield

N/A

Beta

1.37

Laetitia Cousin Biography and Net Worth

What is Laetitia Cousin's net worth?

How old is Laetitia Cousin?

How do I contact Laetitia Cousin?

Has Laetitia Cousin been buying or selling shares of Insulet?

Who are Insulet's active insiders?

Are insiders buying or selling shares of Insulet?